Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,009) Arrow Down
Filter Results: (1,009) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,009)
    • People  (3)
    • News  (261)
    • Research  (632)
    • Events  (1)
    • Multimedia  (6)
  • Faculty Publications  (297)

Show Results For

  • All HBS Web  (1,009)
    • People  (3)
    • News  (261)
    • Research  (632)
    • Events  (1)
    • Multimedia  (6)
  • Faculty Publications  (297)
← Page 22 of 1,009 Results →
  • September 2003 (Revised October 2010)
  • Case

A Pain in the Hip

By: Richard M.J. Bohmer
Describes in detail the process of diagnosing the cause of a sore hip in a young girl. Referred to the emergency room by her pediatrician, the child is subjected to a set of diagnostic tests over a two-day period, each designed to reduce the uncertainty surrounding the... View Details
Keywords: Production; Service Delivery; Service Operations; Performance Improvement; Health Industry
Citation
Find at Harvard
Related
Bohmer, Richard M.J. "A Pain in the Hip." Harvard Business School Case 604-012, September 2003. (Revised October 2010.)
  • May 6, 2020
  • Article

We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic

By: Gary P. Pisano
The ultimate solutions to the COVID-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already... View Details
Keywords: COVID-19; Health Pandemics; Strategy; Leadership
Citation
Find at Harvard
Read Now
Related
Pisano, Gary P. "We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic." Harvard Business Review Digital Articles (May 6, 2020).
  • July – August 2011
  • Article

Deliberate Learning to Improve Performance in Dynamic Service Settings: Evidence from Hospital Intensive Care Units

By: I. M. Nembhard and A. L. Tucker
Dynamic service settings-characterized by workers who interact with customers to deliver services in a rapidly changing, uncertain, and complex environment (e.g., hospitals)-play an important role in the economy. Organizational learning studies in these settings have... View Details
Keywords: Experience and Expertise; Customer Focus and Relationships; Learning; Health Care and Treatment; Service Delivery; Performance Improvement; Quality; Groups and Teams; Cooperation; Health Industry
Citation
Find at Harvard
Related
Nembhard, I. M., and A. L. Tucker. "Deliberate Learning to Improve Performance in Dynamic Service Settings: Evidence from Hospital Intensive Care Units." Organization Science 22, no. 4 (July–August 2011): 907–922.
  • 27 Sep 2011
  • First Look

First Look: September 27

Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and... View Details
Keywords: Sean Silverthorne
  • 2021
  • Working Paper

Who Closed the Schools?

By: Joshua D. Coval
This paper examines the differences in characteristics between U.S. public schools that opted for virtual instruction because of COVID-19, and schools that did not. Much of the variation can be explained by measures of the degree to which districts favored teachers... View Details
Keywords: Public Education; COVID-19; Virtual Learning; Education; Health Pandemics; Teaching; Internet and the Web; Policy; Outcome or Result; United States
Citation
Read Now
Related
Coval, Joshua D. "Who Closed the Schools?" Harvard Business School Working Paper, No. 21-127, June 2021.
  • October 2024
  • Supplement

NOW PT (B)

By: George A Riedel, Allison J. Wigen and Dave Habeeb
Pre-Abstract: Instructors should consider the timing of making videos available to students, as they may reveal key case details.

Abstract: In fall 2021, a team of students from the HBS Impact Investing Fund considered Neurologic Optimal Wellness Physical... View Details
Keywords: Health Care and Treatment; Medical Specialties; Business Model; Investment; Health Industry; United States
Citation
Purchase
Related
Riedel, George A., Allison J. Wigen, and Dave Habeeb. "NOW PT (B)." Harvard Business School Multimedia/Video Supplement 325-702, October 2024.
  • Web

Capstone | MBA

cellular signaling. Recently, it has been appreciated that these drugs can provide benefits to patients with severe mental health disorders including depression and addiction. This project described an... View Details
  • March 2020 (Revised June 2023)
  • Case

EyeControl: Inspiring Communication

By: Paul A. Gompers and Danielle Golan
Eye-controlled communication device startup EyeControl was founded in Tel Aviv, Israel in 2016 by cofounders with a shared personal connection to locked-in syndrome—a neurological disorder that left sufferers cognitively sound, yet paralyzed, with the exception of eye... View Details
Keywords: Health Disorders; Communication Technology; Business Startups; Expansion; Finance; Decision Making; Social Enterprise; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Gompers, Paul A., and Danielle Golan. "EyeControl: Inspiring Communication." Harvard Business School Case 820-078, March 2020. (Revised June 2023.)
  • December 2021
  • Article

Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study

By: Michael Anne Kyle, Renuka Tipirneni, Nitya Thakore, Sneha Dave and Ishani Ganguli
Background
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face potential barriers to timely visits.
Objective
To quantify availability and wait times for new patient... View Details
Keywords: COVID-19; Ambulatory Care; Policy/economics; Access; Telemedicine; Health Pandemics; Health Care and Treatment
Citation
Find at Harvard
Register to Read
Related
Kyle, Michael Anne, Renuka Tipirneni, Nitya Thakore, Sneha Dave, and Ishani Ganguli. "Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study." Journal of General Internal Medicine 36, no. 12 (December 2021): 3766–3771.
  • October 2024
  • Supplement

NOW PT (A)

By: George A Riedel, Allison J. Wigen and Dave Habeeb
Pre-Abstract: Instructors should consider the timing of making videos available to students, as they may reveal key case details.

Abstract: In fall 2021, a team of students from the HBS Impact Investing Fund considered Neurologic Optimal Wellness Physical... View Details
Keywords: Health Care and Treatment; Medical Specialties; Investment; Business Model; Health Industry; United States
Citation
Purchase
Related
Riedel, George A., Allison J. Wigen, and Dave Habeeb. "NOW PT (A)." Harvard Business School Multimedia/Video Supplement 325-701, October 2024.
  • January 2009 (Revised July 2009)
  • Case

Targanta Therapeutics: Hitting a Moving Target

By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
  • 16 Dec 2014
  • First Look

First Look: December 16

share the same ethnic, educational, or career background are more likely to syndicate with each other. This homophily reduces the probability of investment success, and the detrimental effect is most prominent for early-stage investments.... View Details
Keywords: Sean Silverthorne
  • Web

Admissions & Financial Support - Doctoral

deep rigorous study. Applicants are evaluated on their academic records, letters of recommendation, research and work experience, statement of purpose, and potential to conduct independent research with the... View Details
  • Web

Faculty & Advisors | MBA

device and diagnostics development, and software systems development, primarily for accelerating clinical trials and regulatory approvals.... View Details
  • 05 Jul 2006
  • Working Paper Summaries

Implementing New Practices: An Empirical Study of Organizational Learning in Hospital Intensive Care Units

Keywords: by Anita L. Tucker, Ingrid M. Nembhard & Amy C. Edmondson; Health
  • August 2017 (Revised July 2018)
  • Case

MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work

By: Elie Ofek and Amanda Dai
In June 2014, MannKind Corporation announced that after years of development and billions of dollars in expenses, the FDA had finally approved its drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to... View Details
Keywords: Health Care and Treatment; Product Launch; Product Positioning; Marketing Strategy; Adoption; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Ofek, Elie, and Amanda Dai. "MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work." Harvard Business School Case 518-031, August 2017. (Revised July 2018.)
  • April 2024
  • Article

A Machine Learning Algorithm Predicting Risk of Dilating VUR among Infants with Hydronephrosis Using UTD Classification

By: Hsin-Hsiao Scott Wang, Michael Lingzhi Li, Dylan Cahill, John Panagides, Tanya Logvinenko, Jeanne Chow and Caleb Nelson
Backgrounds: Urinary Tract Dilation (UTD) classification has been designed to be a more objective grading system to evaluate antenatal and post-natal UTD. Due to unclear association between UTD classifications to specific anomalies such as vesico-ureteral reflux (VUR),... View Details
Keywords: Health Disorders; Health Testing and Trials; AI and Machine Learning; Health Industry
Citation
Read Now
Related
Wang, Hsin-Hsiao Scott, Michael Lingzhi Li, Dylan Cahill, John Panagides, Tanya Logvinenko, Jeanne Chow, and Caleb Nelson. "A Machine Learning Algorithm Predicting Risk of Dilating VUR among Infants with Hydronephrosis Using UTD Classification." Journal of Pediatric Urology 20, no. 2 (April 2024): 271–278.
  • 02 Jan 2024
  • Research & Ideas

10 Trends to Watch in 2024

The lightning-fast ascent of generative AI isn’t the only sea change on the horizon for businesses in the new year. The global economy is in flux as war, climate change, trade issues, and infrastructure problems demand attention. Many companies continue to struggle to... View Details
Keywords: by Rachel Layne
  • 22 Aug 2012
  • Working Paper Summaries

A Randomized Field Study of a Leadership WalkRounds™-Based Intervention

Background: Leadership WalkRounds have been widely adopted as a technique for improving patient safety and safety climate. WalkRounds involve senior managers directly observing frontline work and soliciting... View Details
Keywords: by Anita L. Tucker & Sara J. Singer; Health

    Someone To Talk To

    Someone To Talk To examines how people use their networks to cope with loss, victimization, failure, and other debilitating stressors. An important part of this process is deciding whom to turn to for support, and both network analysis and common sense... View Details

    • ←
    • 22
    • 23
    • …
    • 50
    • 51
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.